Clinical Trial Update: Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update on refining adjuvant therapy for early-stage non-small cell lung cancer (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Thoraxklinik-Heidelberg gGmbH | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED